Company: CYTK
Filing Date: 2025-03-31
Form Type: PRE 14A
Source: 0001140361-25-011212
Chunk: 33

Company: CYTOKINETICS INC
Filing Date: 2025-03-31
Form: PRE 14A
Chunk 33
---
, and Abigail P. Johnson has sole dispositive power over 11,146,953.56 of these shares of Common Stock. Of these shares, Fidelity Management & Research Company LLC also beneficially owns shares representing 5% or greater of our outstanding shares of Common Stock. |

| (5) | According to its Schedule 13G filed on November 14, 2024, as of September 30, 2024, T. Rowe Price Investment Management, Inc. had sole voting power over 9,667,286 shares of Common Stock and sole dispositive power over 9,689,987 shares of Common Stock. |

| (6) | According to its Schedule 13G filed on February 8, 2024, as of December 29, 2023, each of Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP had shared voting power over 6,036,013 shares of Common Stock, and shared dispositive power over all of these shares of Common Stock, and Wellington Management Company LLP had shared voting power over 5,998,852 shares of Common Stock, and shared dispositive power over 6,325,032 shares of Common Stock. |

| (7) | According to its Schedule 13G/A filed on January 25, 2024, as of December 31, 2023, State Street Corporation had shared voting power over 5,614,958 shares of Common Stock, and shared dispositive power over all of these shares of Common Stock. |

| (8) | Represents (a) 252,613 shares of Common Stock held by Mr. Blum; (b) 2,083 shares of Common Stock held by the Brittany Blum 2003 Irrevocable Trust; (c) 2,083 shares of Common Stock held by the Bridget Blum 2003 Irrevocable Trust; and (d) 1,365,157 shares of Common Stock underlying options granted to Mr. Blum that are exercisable within 60 days of February 28, 2025. Mr. Blum disclaims beneficial ownership of the shares of Common Stock held by the aforementioned trusts. |

| (9) | Represents (a) 26,771 shares of Common Stock held by Mr. Callos; and (b) 216,028 shares of Common Stock underlying options granted to Mr. Callos that are exercisable within 60 days of February 28,